Company intelligence / Profile preview

Trialbee

Ownership: Private
Development stage: Commercial

Overview

Trialbee has demonstrated success in improving patient identification, engagement, and enrollment rates across global clinical trials. Case studies highlight its impact on hard-to-recruit populations in urology, neuromuscular disease diagnostics (including Pompe disease), rare endocrine disorders like Carcinoid Syndrome, oncology trials, as well as its ability to shorten the diagnostic journey through targeted digital outreach. The company’s technology has supported over 70 clinical studies globally. No direct clinical results since it does not develop drugs.

Therapeutic areas: Men's HealthOncologyEndocrinologyRare DiseasesNeurology
Modalities: Not applicable
Industry: Contract Research Organization

Partnerships

Savvy CooperativeTrialHub

Beyond the preview

Go deeper on Trialbee.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trialbee.

Explore the full profile